SOX2 and cancer: current research and its implications in the clinic

by Weina, Kasia, Utikal, Jochen
Published 2014

Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies

by Utikal, Jochen, Schadendorf, Dirk, Ugurel, Selma
Published 2007

Systemic Therapy of Non-Resectable Metastatic Melanoma

by Orouji, Azadeh, Goerdt, Sergij, Utikal, Jochen
Published 2010

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

by Umansky, Viktor, Blattner, Carolin, Gebhardt, Christoffer, Utikal, Jochen
Published 2016

Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia: Case Report

by Orouji, Elias, Ziegler, Birgit, Umansky, Viktor, Gebhardt, Christoffer, Utikal, Jochen
Published 2014

Loss of tumorigenic potential upon transdifferentiation from keratinocytic into melanocytic lineage

by Fehrenbach, Sabrina, Novak, Daniel, Bernhardt, Mathias, Larribere, Lionel, Boukamp, Petra, Umansky, Viktor, Utikal, Jochen
Published 2016

Desmoglein 2 Depletion Leads to Increased Migration and Upregulation of the Chemoattractant Secretoneurin in Melanoma Cells

by Peitsch, Wiebke K., Doerflinger, Yvette, Fischer-Colbrie, Reiner, Huck, Volker, Bauer, Alexander T., Utikal, Jochen, Goerdt, Sergij, Schneider, Stefan W.
Published 2014

SOX5 is involved in balanced MITF regulation in human melanoma cells

by Kordaß, Theresa, Weber, Claudia E. M., Oswald, Marcus, Ast, Volker, Bernhardt, Mathias, Novak, Daniel, Utikal, Jochen, Eichmüller, Stefan B., König, Rainer
Published 2016

Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

by El-Battrawy, Ibrahim, Lang, Siegfried, Zhao, Zhihan, Akin, Ibrahim, Yücel, Gökhan, Meister, Sophie, Patocskai, Bence, Behnes, Michael, Rudic, Boris, Tülümen, Erol, Liebe, Volker, Tiburcy, Malte, Dworacek, Jennifer, Zimmermann, Wolfram-Hubertus, Utikal, Jochen, Wieland, Thomas, Borggrefe, Martin, Zhou, Xiao-Bo
Published 2016

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

by Zimmer, Lisa, Eigentler, Thomas K., Kiecker, Felix, Simon, Jan, Utikal, Jochen, Mohr, Peter, Berking, Carola, Kämpgen, Eckhart, Dippel, Edgar, Stadler, Rudolf, Hauschild, Axel, Fluck, Michael, Terheyden, Patrick, Rompel, Rainer, Loquai, Carmen, Assi, Zeinab, Garbe, Claus, Schadendorf, Dirk
Published 2015

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

by Zimmer, Lisa, Vaubel, Julia, Mohr, Peter, Hauschild, Axel, Utikal, Jochen, Simon, Jan, Garbe, Claus, Herbst, Rudolf, Enk, Alexander, Kämpgen, Eckhart, Livingstone, Elisabeth, Bluhm, Leonie, Rompel, Rainer, Griewank, Klaus G., Fluck, Michael, Schilling, Bastian, Schadendorf, Dirk
Published 2015

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for ad...

by Kaehler, Katharina C., Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Haalck, Thomas, Heinzerling, Lucie, Kornek, Thomas, Livingstone, Elisabeth, Loquai, Carmen, Maul, Lara Valeska, Lang, Berenice M., Schadendorf, Dirk, Stade, Barbara, Terheyden, Patrick, Utikal, Jochen, Wagner, Tobias, Hauschild, Axel, Garbe, Claus, Augustin, Matthias
Published 2016